El gigante farmacéutico Boehringer Ingelheim, multinacional alemana de origen familiar … Human Pharma Regions – CXE de  Boehringer Ingelheim. Uno de los principales objetivos …

… patient adherence and outcomes. Boehringer Ingelheim, which already has four … new projects per year, with Boehringer Ingelheim leading clinical development, regulatory … grants target exclusivity to Boehringer Ingelheim and includes upfront payments …

… , 18 mcg/capsule) by Boehringer Ingelheim Pharmaceuticals, Inc. To read more … , Edesa Biotech, Light Chain Biosciences, Boehringer Ingelheim, Genentech, Windtree Therapeutics, Biomarck Pharmaceuticals …

… , “The strategic collaboration with Boehringer Ingelheim marks a transformational moment for … on product net sales. Boehringer Ingelheim and Re-Vana Therapeutics Announce … Develop Long-Acting Ophthalmic Therapies Boehringer Ingelheim July 28, 2025 https:…

… Amgen, Bayer, Beiersdorf, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, … AbbVie, Almirall, Amgen, Biogen, Boehringer Ingelheim, BMS, Celgene, Centocor, Eli … Hermal, Amgen, Biogen, BMS, Boehringer Ingelheim, Celgene, Celltrion HC, Foamix, …

… sent to AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly …

… allowed cattle fully vaccinated with Boehringer Ingelheim’s Bultavo-3 vaccine, to …

… with Calliditas, Novartis, Otsuka, and Boehringer Ingelheim. References

… -relevant honoraria from AbbVie, Amgen, Boehringer Ingelheim, Leopharma, Novartis, Pfizer, Sanofi, Incyte …

… such as AstraZeneca, GSK, and Boehringer Ingelheim. The standard of care typically … to be seen. Beyond GSK, Boehringer Ingelheim and AstraZeneca may be the …